A new study shows that a single dose of CBD may reduce alcohol cravings, offering the first clinical evidence that it could ...

CBD did not meet primary end point comparing preingestion to postingestion anxiety, but resulted in lower anxiety levels ...

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects ...

Study: Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive ...

The findings of this randomized clinical trial show that cannabidiol (CBD) can be used safely in women with advanced breast cancer and clinical anxiety. Although the study did not meet its primary end ...

Cannabidiol (CBD) had no effect on scan-related anxiety (scanxiety), but it significantly eased overall anxiety in women with ...

It has been four years since the 2018 Farm Bill descheduled hemp and allowed cannabidiol (CBD) to be sold legally. Has the market lived up to the hype?

This study seeks people age 18 or older with ASD and who have a significant mood disorder or other behaviors that interfere with function and quality of life ...

Cannabidiol Market is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a CAGR of 16.3% from 2024 to 2031 Mr. Shah Coherent Market Insights Pvt.

UK food regulators have lowered the recommended safe daily dose of cannabidiol (CBD), a cannabis extract present in many different High Street products, including drinks and snacks. The Food ...

Cannabidiol 1 is a small molecule commercialized by Cardiol Therapeutics, with a leading Phase II program in Pericarditis.